What is VaxPro?
VaxPro operates as a specialized provider of comprehensive on-site vaccination and health screening solutions. With a service portfolio that encompasses flu vaccinations, COVID-19 immunizations, tuberculosis testing, and biometric screenings, the company addresses critical public health needs for corporate offices, educational institutions, and senior living communities. By maintaining a strict adherence to HIPAA compliance and providing insured, efficient medical logistics, VaxPro has established itself as a reliable partner in the preventative healthcare space. Their business model simplifies complex health management for organizations, effectively bridging the gap between clinical necessity and workplace convenience through a 25-year track record of operational excellence.
How much funding has VaxPro raised?
VaxPro has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in VaxPro
PPP
Public-Private Partnership
What's next for VaxPro?
With the recent influx of capital, VaxPro is expected to prioritize the expansion of its service network and the integration of advanced health data analytics. The strategic roadmap likely involves deepening its penetration into the corporate wellness sector while optimizing its logistics chain to handle higher volumes of biometric screenings. As the company navigates this Series B/C stage, the focus will shift toward long-term sustainability and the potential for technological enhancements in patient data management. By scaling its infrastructure, VaxPro aims to solidify its market leadership, ensuring that its on-site health solutions remain the gold standard for organizations seeking to prioritize employee and community well-being in an increasingly health-conscious corporate environment.
See full VaxPro company page
